Early pancreatic carcinogenesis - risk factors, early symptoms, and the impact of antidiabetic drugs
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F16%3A10325053" target="_blank" >RIV/00064165:_____/16:10325053 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/16:10325053 RIV/61383082:_____/16:00000141
Result on the web
<a href="http://dx.doi.org/10.1097/MEG.0000000000000646" target="_blank" >http://dx.doi.org/10.1097/MEG.0000000000000646</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/MEG.0000000000000646" target="_blank" >10.1097/MEG.0000000000000646</a>
Alternative languages
Result language
angličtina
Original language name
Early pancreatic carcinogenesis - risk factors, early symptoms, and the impact of antidiabetic drugs
Original language description
Risk factors (long-term diabetes, obesity) and early symptoms (new-onset diabetes, loss of weight, or persistent low body mass) are the initial symptoms of pancreatic carcinogenesis. They may be influenced by antidiabetic drugs and their correct evaluation is a prerequisite for early diagnosis of pancreatic cancer (PC). We review the risk factors, early symptoms, and the impact of antidiabetic drugs on early pancreatic carcinogenesis. The main source of data was the database Medline/PubMed and abstracts of international congresses (DDW, UEGW). The risk factors and early symptoms are integral components of the familial PC surveillance and sporadic PC screening. Preventive programs should always be include multistep and multidisciplinary procedures. The correct evaluation of antidiabetic drugs and their interactions with other components of pancreatic carcinogenesis may influence the early diagnosis of PC.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FE - Other fields of internal medicine
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NT14254" target="_blank" >NT14254: Early Diagnosis of Pancreatic Adenocarcinoma: Surface Proteases and Specific Biomarkers</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
European Journal of Gastroenterology and Hepatology
ISSN
0954-691X
e-ISSN
—
Volume of the periodical
28
Issue of the periodical within the volume
7
Country of publishing house
US - UNITED STATES
Number of pages
7
Pages from-to
"E19"-"E25"
UT code for WoS article
000378613600001
EID of the result in the Scopus database
2-s2.0-84966603268